The revenue stands at ₹304.17 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 17.42 per cent from ₹368.33 crore. This corresponds to a year-on-year *(YoY) growth of 15.57 per cent.
Operating Profit stands at ₹14.00 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 53.24 per cent from ₹29.94 crore. This corresponds to a year-on-year *(YoY) growth of 348.23 per cent.
PBDT stands at ₹14.24 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 61.24 per cent from ₹36.74 crore. This corresponds to a year-on-year *(YoY) growth of 194.21 per cent.
Profit Before Tax stands at ₹3.29 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 87.27 per cent from ₹25.84 crore. This corresponds to a year-on-year *(YoY) growth of 157.82 per cent.
Net Profit stands at ₹3.22 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 87.54 per cent from ₹25.84 crore. This represents a 156.59 per cent year-on-year *(YoY) growth for the same year.
in ₹ cr
in ₹ cr
in ₹ cr
in ₹ cr
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Orchid Pharma | 0.31% | 15.42% | 6.30% | 11.37% | 115.01% | 49.35% |
| Symbiotec Pharma | -5.27% | 1.47% | -3.08% | -3.08% | -3.08% | -3.08% |
| Morepen Labs. | 2.86% | 1.41% | 28.74% | 135.02% | 234.75% | 140.94% |
| SPARC | 3.99% | 6.47% | 5.46% | -9.34% | 83.83% | 49.73% |
| Jeena Sikho | 1.55% | 6.62% | 2.29% | -9.81% | -13.80% | -35.82% |
| Senores Pharma. | -0.11% | -1.77% | -9.08% | 8.16% | 88.73% | 96.34% |
| IOL Chemicals | 3.17% | 4.63% | 22.10% | 57.77% | 167.79% | 80.52% |
Chairman(Non Exe)&Dir(Non-Ind) : R G Agarwal
Executive Director & MD : Manish Dhanuka
E D & Wholetime Director : Mridul Dhanuka
Non-Exec & Non-Independent Dir : Arjun Dhanuka
Independent Non Exe. Director : Dharam Vir
Independent Non Exe. Director : Manoj Goyal
Independent Non Exe. Director : Tanu Singla
Independent Non Exe. Director : Shubha Singh
Company Sec. & Compli. Officer : Kapil Dayya